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Abstract
Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has
not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital stroke admissions and in-
hospital mortality in tertiary referral hospitals from North-West Spain.
Methods: Spanish multicenter retrospective observational study based on data from tertiary hospitals of the
NORDICTUS network. We recorded the number of patients admitted for ischemic stroke between 30 December
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Molecular, Universidad de Valladolid – Consejo Superior de
Investigaciones Cientı́ficas, Madrid, Spain
9Stroke Unit, Department of Neurology, Hospital Universitario de Araba,
Vitoria, Spain
10Department of Neurology, Complejo Hospitalario Universitario de
Vigo, Vigo, Spain
11A Coruña Biomedical Research Institute, Department of Neurology,
Complexo Hospitalario Universitario A Coruña, A Coruña, Spain
12Department of Neurology, Hospital Universitario de Cabueñes, Gijón,
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2019 and 3 May 2020, the number of IVT and EVT procedures, and in-hospital mortality.
Results: In the study period, 2737 patients were admitted with ischemic stroke. There was a decrease in the weekly
mean admitted patients during the pandemic (124 vs. 173, p<0.001). In-hospital mortality of stroke patients increased
significantly (9.9% vs. 6.5%, p¼ 0.003), but there were no differences in the proportion of IVT (17.3% vs. 16.1%,
p¼ 0.405) or EVT (22% vs. 23%, p¼ 0.504).
Conclusion: We found a decrease in the number of ischemic stroke admissions and an increase in in-hospital mortality
during the COVID-19 epidemic in this large study from North-West Spain. There were regional changes within the
network, not fully explained by the severity of the pandemic in different regions.
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Introduction
Since the first reported case in early December 2019,
severe acute respiratory coronavirus 2 (SARS-CoV-2)
infection, known as Coronavirus Disease 2019
(COVID-19), has become pandemic so rapidly that
healthcare systems have been overwhelmed all around
the world.1–3 In Spain, by 16th May, 231,350 cases and
27,650 deaths had been confirmed.4 Many extreme
measures have been taken to contain the spread of
the disease, such as locking down communities, which
could have affected the optimal stroke care.
Spain has been one of the countries more heavily
stricken by SARS-CoV-2, but this pandemic has not
affected all regions equally. While some registered
more than 3000 cases per day, others did not reach
120. In this context, there is general uncertainty in
Spain regarding the real impact of the COVID-19 out-
break on hospital stroke admissions. Moreover, the
necessary measures taken by hospitals, aiming to
increase healthcare professionals’ protection, and gov-
ernment measures to protect at risk patients from
unnecessary admission, may have jeopardized the qual-
ity of care provided to stroke patients.
We aimed to analyze the impact of the COVID-19
pandemic outbreak on hospital ischemic stroke admis-
sions as well as the use of reperfusion therapies and in-




This Spanish multicenter retrospective observational
study was based on the NORDICTUS network data.
NORDICTUS is a research and innovation network in
cerebrovascular diseases that brings together all public
hospitals with stroke units in North-West Spain, with a
global catchment area of 11.5 million inhabitants.
According to its territorial division, the Spanish State
is divided into 17 autonomous communities (AC) and
two autonomous cities, both groups being the highest
or first-order political and administrative division in the
country. AC are divided into 50 total provinces and
NORDICTUS covers 23, grouped in 8 AC represented
in Figure 1, with the SARS-CoV-2 seroprevalence in
each region by 14th May. Sixteen of the 18 referral
centers of the network offered their data. During pan-
demic, none of the participating regions changed its
prehospital ischemic stroke care.
Epidemiological data of COVID-19 cases were
obtained from the Ministry of Health, Consumer
Affairs and Social Welfare. It considers confirmed
cases those who have a positive polymerase chain reac-
tion for SARS-CoV-2. Due to a change in the counting
Figure 1. Map of Spain. Autonomous communities being
part of NORDICTUS network are colored in gray. Red cir-
cles represent the percentage of seroprevalence in each
region.
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system in the AC of Galicia, historical data from that
administration were obtained from its regional
Department of Health (Conselleria de Sanidade).5,6
Study population
We reviewed the data from tertiary hospitals of the
NORDICTUS network and recorded the number of
patients admitted for ischemic stroke between 30
December 2019 and 3 May 2020. We grouped the
cases in two periods, according to the setting of the
state of emergency in Spain (14 March 2020) and con-
sidering the start of the COVID-19 period as the 11th
week (W11) of 2020. We also recorded the number of
intravenous (IVT) and endovascular treatments (EVT),
as well as wake-up strokes or unknown-onset time.
Finally, in-hospital mortality was recorded and ana-
lyzed as the key quality indicator of the stroke care
process. Sixteen centers from eight different Spanish
AC participated in this study.
Statistical analysis
We used descriptive statistics to compare the incidence
of stroke admissions before and after the setting of the
state of emergency in Spain, expressed in strokes per
week (W) and the differences between the other study
variables (IVT, EVT, in-hospital mortality, and wake-up
strokes or unknown-onset time) in those periods.
Qualitative variables are described using counts and per-
centages, and continuous quantitative variables as
means with standard deviation and medians with inter-
quartile ranges when necessary. Comparisons between
groups were made using chi-square tests for comparing
categorical variables and the Student test or Mann-
Whitney U test for continuous variables; p values< 0.05
were considered statistically significant. Statistical ana-
lysis was performed with SPSS Statistics 20.
Ethics
The study was approved by the local Ethics Committee
of each participating center. Treatment of every data
obtained in the registry was done following the Spanish
data protection law (Data Protection and Digital
Rights Guarantee Act).
Results
In total, 2737 patients with ischemic stroke (male 1476,
53.5%; average age 73.5 years, SD 6.0) were attended
to any of the hospitals participating in the study
between 30 December 2019 and 3 May 2020. Table 1
shows global and specific results for each hospital and
grouped by regions. Globally, there was a weekly
average of 173 (IQR (interquartile range) 171.0–178.5)
ischemic stroke admissions before the setting of
the state of emergency against 124 (IQR 114.8–134.3)
afterward (p< 0.001) (Table 1). This drop in stroke
cases occurred progressively from week 11 (W11, 9–
15th March), persisting over time despite the decrease
in confirmed cases of COVID-19, but it did not occur
homogeneously in each hospital; the reduction was only
significant in 6 out of 16 centers (Table 1, Figure 2).
There were no differences in the proportion of ische-
mic stroke undergoing IVT (17.3% vs. 16.1%,
p¼ 0.405) or EVT (22% vs. 23%, p¼ 0.504) during
the pandemic or in the proportion of wake-up/
unknown-onset strokes (39.4% vs. 39.1%, p¼ 0.887).
In-hospital mortality of stroke patients increased sig-
nificantly during the COVID-19 pandemic (6.5% vs.
9.9%, p¼ 0.003) (Table 1).
Discussion
This study demonstrates a decrease in stroke admis-
sions and an increase in stroke mortality during the
COVID-19 pandemic across 16 centers within the
NORDICTUS network including Aragón, Asturias,
Cantabria, Castilla y León, Euskadi, Galicia, La
Rioja, and Navarra in North-West Spain.
On 14 March 2020, the Government of Spain imple-
mented extraordinary measures to control viral trans-
mission, restricting free mobility over the entire country
equally. This was reinforced from 31st March to 11th
April, with essential workers the only ones allowed to
leave their homes. These restrictions have been main-
tained until 4th May (W18). Since then, there has been
a gradual return to normal by stages and which has
varied between provinces. To date, Castilla y León is
among the territories which maintain the most restrict-
ive measures in Spain.
A decrease in hospital admissions for ischemic
stroke in Europe is a situation that has already been
referred to in different scientific media,7–9 but just
described in two regional studies.10,11 This is the first
study of which we are aware describing this phenom-
enon in hospitals from different regions throughout
a wide coverage area in this continent. We found a
decrease in the absolute number of ischemic strokes
admissions, and although this was observed in all of
the hospitals participating in the study, it only reached
statistical significance in 6 out of 16 centers. If we group
them by AC, the proportion increases so that only three
out of eight territories (Cantabria, La Rioja, and
Navarra; uni-provincial AC) did not show a significant
decrease.
The magnitude of the decrease varied markedly
between study centers. This varied from a drop in ische-
mic stroke cases of more than 50%, in three most
International Journal of Stroke, 0(0)
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Figure 2. Case numbers pre- and during COVID-19 pandemic in NORDICTUS network regions, from 30 December 2019 (W1)
to 3 May 2020 (W18).
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affected hospitals compared to a drop of less than 10%
drop in the three least affected hospitals (Table 1). In
some cases, the variations were seen even despite being
in the same AC and apparently with no correlation with
the COVID-19 cases per week curves for each region
(Figure 2). One example is the steep decline observed in
hospitals from Asturias, which was less effected by
COVID-19 cases than other regions.
Possible explanations for the decrease in ischemic
stroke admissions have been suggested.10–12 These
include changes in social behavior or attitude, minor
non-disabling strokes staying at home, or admission
to hospital isolation units where stroke might not be
the major issue, or not enough attention being made to
diagnose stroke. An argument against small strokes not
being referred to hospital is our regional study from
Aragón, one of the AC within the NORDICTUS net-
work, in which we did not find a higher proportion of
patients with higher NIHSS or lower ASPECTS com-
pared to the pre-COVID period.10 Others speak about
a possible real decrease in the incidence of strokes due
to a reduction of risk factors such as air pollution.9,13
The increase in mortality, above the usual values in
our area,14 could be explained by some of the previ-
ously described situations, or others such as fewer
minor stroke admissions, increasing the proportion of
severe ischemic strokes. It may also reflect an increase
in stroke severity in patients with co-existent COVID-
19 infection.15
Some authors have described a decrease in the
number of IVT and EVT during this period.11 We
also found this, but with no change in the proportion
of treatments performed, similar to the findings of
Zhao et al., who suggest the drop in the absolute
number of IVT and EVT cases merely reflects the
decline in stroke admissions.12
To the best of our knowledge, this study offers the
biggest European sample to analyze the influence of
COVID-19 pandemic in ischemic stroke admissions.
We found a decrease in the number of ischemic
stroke admissions and an increase in in-hospital mor-
tality. Healthcare systems should be rapidly adapted to
implement systems for COVID-19 care, but also to
ensure the usual and effective stroke care despite
system reorganizations. Since stroke is a life-threaten-
ing condition, it is important not to neglect the usual
level of stroke care regardless of the difficult situation
derived from the COVID-19 pandemic.
Limitations
Our study has some limitations. The main limitation is
inherent to its retrospective, observational nature.
Besides, we did not investigate the incidence of virus
infection among patients with stroke or whether it
affected stroke outcomes. We did not obtain other
stroke characteristics that could help to analyze the
causes of the increasing mortality.
Second, although we analyzed data from sixteen
hospitals with stroke units belonging to eight AC
from the North of Spain, some ischemic strokes in
the region are not admitted to these hospitals but
instead to small hospitals without stroke units.
However, due to their role as reference centers and as
the hospitals with the highest volume of stroke patients
in the area, we believe our data give a valid representa-
tion of the impact of COVID-19 in ischemic stroke over
the whole region.
Finally, our results might not be extrapolated to
other countries or regions with different stroke care
protocols and different social and healthcare responses
to the COVID-19 pandemic.
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